Corporate Banner
Satellite Banner
Pharma Outsourcing
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Roowin Transfers its Operations to Riom

Published: Wednesday, December 26, 2012
Last Updated: Wednesday, December 26, 2012
Bookmark and Share
CRO moves into immediately operational premises to handle increase in demand for fine chemistry services, and to bring clients the benefit of facilities.

Roowin SA has announced that it has moved into new premises in Riom, near Clermont-Ferrand, in the Auvergne region.

The move will strengthen Roowin’s position as one of the few companies in France that offers a comprehensive range of services, from early-stage research to the production of GMP batches for phase I and II clinical trials. This relocation also represents a new milestone in the company’s development.

The company is moving into 1,500 square metres of premises at Riom-La Varenne that are currently owned by Schering-Plough. They include laboratories complying with regulatory GLP (good laboratory practice) and GMP (good manufacturing practice) standards, as well as offices and warehousing.

These facilities have 50 per cent more space than Roowin’s old premises and incorporate cutting-edge equipment that will enable the company to increase the quantities that can be produced and offer an even higher quality of the services it provides to its clients.

The new equipment from which its clients will benefit includes an LC/NMR 500 MHz machine combining liquid chromatography with nuclear magnetic resonance for more rapid and accurate screening.

Only a few laboratories in France have access to this technology. In addition, Roowin is now equipped with ultra-performance liquid chromatography/mass spectrometry (UPLC/MS) instruments, infrared equipment, and gas chromatography-mass spectrometry (GC-MS) technology.

In the area of synthesis, Roowin can now undertake low-temperature work as the result of acquiring a liquid nitrogen unit operating at minus 80C.

The move is being welcomed by local authorities. “Keeping industrial activities going at the Schering-Plough site in La Varenne is a priority for Riom town council, the regional development office of the department of Puy de Dome, the Clermont-Ferrand Community, and the Community of District Councils of Limagne-D’Ennezat, one of the founder members of the future joint Biopole Clermont Limagne association,” explained Herve Prevoteau, director of the Clermont Limagne biocluster.

“Roowin is a large independent firm in the fine chemistry sector, and we are going to help it grow still further to our mutual benefit in terms of job and wealth creation. It will find its full place in the pharmaceutical industry of the Auvergne region.”

“It was hard to find a place that corresponded to all our technical needs,” said Patrice Rool, the chairman of Roowin. “That is why we are delighted to be moving to Riom, which offers all the advantages we were looking for. We are planning to develop our activities further and in particular to invest in additional clean rooms.”

Roowin began the move into its new premises on May 1. The operation is being spread over two months to ensure continuity of service to the company’s clientele.


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,400+ scientific posters on ePosters
  • More than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Experimental MERS Vaccine Shows Promise in Animal Studies
A two-step regimen of experimental vaccines against Middle East respiratory syndrome (MERS) prompted immune responses in mice and rhesus macaques, report National Institutes of Health scientists who designed the vaccines.
Young South African Women can Adhere to Daily PrEP Regimen as HIV Prevention
NIH-funded study finds men in Bangkok, Harlem also successful in taking daily dose.
Researchers Find Key Player in Diabetic Kidney Disease Through Power of Metabolomics
Discovery could lead to new and better diagnostic marker for chronic kidney disease.
Immunotherapy Shows Promise for Myeloma
A strategy, which uses patients’ own immune cells, genetically engineered to target tumors, has shown significant success against multiple myeloma, a cancer of the plasma cells that is largely incurable.
Santhera Announces First Patient Dosing with Omigapil in CMD
Company announces full patient recruitment of CALLISTO study.
Study Shows Promise of Precision Medicine for Most Common Type of Lymphoma
The study appeared online July 20, 2015, in Nature Medicine.
HIV Control Through Treatment Durably Prevents Heterosexual Transmission of Virus
NIH-funded trial proves suppressive antiretroviral therapy for HIV-infected people effective in protecting uninfected partners.
Adaptimmune's Novel Cancer Therapeutics Show Positive Clinical Trial Results
The company has announced that positive data from its Phase I/II study of its affinity enhanced T-cell receptor (TCR) therapeutic targeting the NY-ESO-1 cancer antigen in patients with multiple myeloma has been published.
Early Antiretroviral Therapy Prevents Non-AIDS Outcomes in HIV-infected People
NIH-supported findings illustrate manifold benefit of therapy.
Adaptimmune’s NY-ESO-1 TCR-engineered T-Cells Demonstrate Durable Persistence
Study has been published in Nature Medicine.
Scroll Up
Scroll Down
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,400+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!